3 min read

Quality management in a community pharmacy vs a pharma QA department: same principles, different scale

A community pharmacy and a pharmaceutical manufacturer may seem worlds apart. One serves patients across a counter; the other produces millions of units under GMP.
Quality management in a community pharmacy vs a pharma QA department

A community pharmacy and a pharmaceutical manufacturer may seem worlds apart. One serves patients across a counter; the other produces millions of units under GMP. Yet both run on the same quality principles: defined procedures, trained people, controlled records, handling of errors and continual improvement.

I have worked in hospital and community pharmacy for more than a decade across three countries, and completed an MSc in Drug Sciences focused on safety and regulation. This article compares the two worlds and shows what transfers between them.

The shared foundation

The international model for a pharmaceutical quality system is ICH Q10 (International Council for Harmonisation [ICH], 2008). It describes four core elements:

  1. Process performance and product quality monitoring
  2. Corrective and preventive action (CAPA)
  3. Change management
  4. Management review

These are supported by knowledge management and quality risk management (ICH, 2008, 2023). Remarkably, each element has a direct equivalent in a well-run pharmacy.

Side by side

Quality elementCommunity pharmacyPharmaceutical QA
ProceduresWritten procedures for dispensing, counselling, storage and controlled substancesSOPs and work instructions in a controlled document system
TrainingOnboarding and regular team trainingDocumented training curricula linked to each SOP version
VerificationDouble-check of prescriptions before dispensingSecond-person verification and QA review of batch records
MonitoringFridge temperature logs, expiry checks, error trackingProcess monitoring, environmental monitoring, trend analysis
ErrorsNear-miss and dispensing error reportingDeviation management and root cause investigation
ImprovementChanging a procedure after an incidentCAPA with effectiveness checks
ChangeIntroducing new software or a new workflowFormal change control with impact assessment
OversightCantonal inspections, internal auditsSwissmedic inspections, internal audits, supplier audits
LeadershipThe responsible pharmacist reviews quality issuesManagement review of quality metrics

Where the worlds differ

The principles are shared, but several differences are important.

Scale and consequence. A dispensing error usually affects one patient. A manufacturing error can affect an entire batch distributed to thousands. This is why manufacturing controls are more extensive and formal (European Commission, 2013).

Independence of quality. In industry, quality assurance is organisationally independent from production (European Commission, 2014). In a pharmacy, the same pharmacist often dispenses and checks quality.

Validation. Manufacturers must validate processes, equipment, computer systems and analytical methods (European Commission, 2015). Pharmacies rely mostly on qualified suppliers and established systems.

Batch release. In manufacturing, a responsible person must certify each batch before release (Medicinal Products Licensing Ordinance [AMBV], 2018). In a pharmacy, the closest equivalent is the final pharmacist check before handing a medicine to a patient.

Regulatory interfaces. Pharmaceutical QA connects to marketing authorisation dossiers, variations and global quality agreements, which do not exist at pharmacy level.

What transfers directly

Several habits developed in pharmacy translate straight into pharmaceutical quality roles:

  • Documenting at the time of the activity, not later.
  • Checking against a reference, whether a prescription against the patient history or a batch record against the master instructions.
  • Escalating doubt, rather than resolving it silently.
  • Thinking in root causes, for example asking why a dispensing near-miss happened, not just correcting it.
  • Communicating across professions, with doctors, nurses, suppliers and authorities.

In hospital practice, coordinating medication planning with surgical teams and maintaining rigorous records showed me how quality depends on clear interfaces between people. In community pharmacy, supporting the lead pharmacist in maintaining quality and safety standards gave me practical experience of running quality as an everyday routine.

How the quality toolkit expands in industry

In industry, the same principles are applied with an expanded toolkit: GMP-specific requirements, validation concepts, electronic quality management and document systems, and formal risk assessment methods such as those in ICH Q9 (ICH, 2023).

My MSc training in regulatory aspects, toxicology and early safety assessment, together with GCP certification and continuing education in pharmaceutical legislation and good practice, connects directly to this toolkit.

Why this matters to employers

Quality departments benefit from people who understand where medicines end up. Pharmacists know how a labelling ambiguity, a confusing package or an unclear instruction affects real patients (Kohn et al., 2000). That perspective helps quality teams prioritise risks that truly matter.

Key takeaways

  • Pharmacies and pharmaceutical companies share the same quality principles, described in ICH Q10.
  • Industry adds scale, independence of QA, validation and formal batch release.
  • Pharmacy habits such as contemporaneous documentation, verification and escalation transfer directly.

References

European Commission. (2013). EudraLex Volume 4: EU guidelines for good manufacturing practice for medicinal products for human and veterinary use – Chapter 1: Pharmaceutical quality system. https://health.ec.europa.eu

European Commission. (2014). EudraLex Volume 4: EU guidelines for good manufacturing practice for medicinal products for human and veterinary use – Chapter 2: Personnel. https://health.ec.europa.eu

European Commission. (2015). EudraLex Volume 4: EU guidelines for good manufacturing practice for medicinal products for human and veterinary use – Annex 15: Qualification and validation. https://health.ec.europa.eu

International Council for Harmonisation. (2008). Pharmaceutical quality system Q10. https://www.ich.org

International Council for Harmonisation. (2023). Quality risk management Q9(R1). https://www.ich.org

Kohn, L. T., Corrigan, J. M., & Donaldson, M. S. (Eds.). (2000). To err is human: Building a safer health system. National Academies Press.

Medicinal Products Licensing Ordinance [AMBV] of 14 November 2018, SR 812.212.1 (Switzerland). https://www.fedlex.admin.ch